Science can be a motivating factor to success when it comes to healthcare. As the world grows, healthcare is not only becoming a sector meant to provide better services to patients, but also grows as a business in providing quality healthcare. Jim Tananbaum is one of the few strategists and entrepreneurs that have been committed to changing health care industry by investing heavily in the sector. Currently, he is the chief executive officer at the Forsite capital. This firm invests in emerging health care institutions and offers advice to healthcare leaders operating as business people in the health sector.
As the leading strategist at Forsite capital, it has grown to be one of the best firms in investing in the healthcare sector. Jim’s passion is seen in how tirelessly he is motivated to invest more in the area of health. His ambition is good for humanity and business since he has managed to emerge in the global market as a powerful capitalist. The greatest advantage he has is the 25 years’ experience, operating in the healthcare environment. He has established other health care investments projects that have so far been successful.
According to Market Wired, this year, he was included on the Forbes’ Midas list where global top 100 successful capitalist and investors were included, reveals Ideamensch. It is worth noting this is the third consecutive time that he has managed to appear on the list. The consistency in being successful is evident on how he has managed to invest in over 78 health care firms globally. Jim Tananbaum participated in the establishment of Geitex Pharmaceutical. It is no surprise that when this company introduced its new drugs to the market, the total sales were beyond imagination. A whopping $1.6 billion.
He believes in a prosperous future that will lead in provisions of better research, manufacture of drugs, and health care as a business opportunity. That is why he offers investments capital to emerging healthcare institution and aspiring leaders in the sector so that they can participate in the evolution of heath care. These investments are given at affordable rates, to encourage the smaller healthcare firms to grow and become national and global brands.